PKHD1 and autosomal recessive polycystic kidney disease: We utilized CRISPR‐Cas9 to target exon 5 of PKHD1, a region identified to have a high number of pathogenic variants reported in ARPKD patients in the Leiden Open Variation Database (Fokkema et al., 2011).